Bayer announces key leadership changes for its Crop Science division
Brian Naber appointed as new commercial lead for North America and Malu Nachreiner to become new commercial lead for Asia Pacific, both effective March 1, 2024 / Oliver Rittgen appointed as Chief Financial Officer, Crop Science, effective February 1, 2024 / Sascha Israel is heading the division’s Product Supply organization, effective January 1, 2024 / Amanda McClerren is new Chief Information Officer, Head of Digital Transformation and Information Technology, effective January 1, 2024 / Jessica Christiansen serves as new Head of Crop Science Communications, effective January 1, 2024
Monheim, January 10, 2024 – Bayer is applying several key changes to the Executive Leadership Team of its Crop Science Division. The new setup will support the company to shape agriculture for farmers, consumers, and the planet, and to deliver against the ambition of becoming the leader in regenerative agriculture.
Brian Naber will assume the position as commercial lead for the region North America from Jackie Applegate who will be retiring from Bayer after 31 years with the company. Consequently, Malu Nachreiner, currently serving as Senior Bayer Representative and Country Division Head for Crop Science in Brazil, is going to succeed Brian Naber as commercial lead for the region Asia Pacific. Both changes will become effective as of March 1, 2024. As of February 1, Oliver Rittgen will serve as the division’s new Chief Financial Officer following Kelly Gast who retired after almost 30 years with the company. Oliver’s current assignment is Chief Financial Officer for Bayer’s Consumer Health Division.
Further changes have become effective with the beginning of 2024: Sascha Israel has been appointed as Head of Product Supply succeeding Dirk Backhaus who retired after 27 years with Bayer. Amanda McClerren, former Head of Crop Science R&D Digital Transformation and Information Technology is going to take over Sascha’s former role as Chief Information Officer, Head of Digital Transformation and Information Technology. Finally, Jessica Christiansen assumes the position as Head of Crop Science Communications after having led the division’s Sustainability and Business Stewardship Team. She is taking over from Tom Armitage who decided to pursue further career opportunities outside of Bayer.
“With the new setup of the Crop Science Executive Leadership Team, we are perfectly positioned to further drive our vision of regenerative agriculture and to deliver much needed innovations to farmers,” said Rodrigo Santos, member of the Board of Bayer AG and president of the company’s Crop Science division. “I am looking forward to working together with this team to tackle some of the most important topics of our time: achieving food security and fighting climate change at the same time. To this end, we will continue to support our customers to produce more while restoring more. I would like to thank Jackie, Kelly, Dirk, and Tom for their dedicated service to Bayer and their outstanding achievements over the last years. They all will leave a lasting legacy, in particular for the Crop Science division.”
More information on the Executive Leadership Team of Bayer’s Crop Science division can be found online.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.